Talquetamab: This medication is being tested in combination with other treatments to see how well it works for patients with relapsed or refractory myeloma. It is a new type of therapy that targets specific proteins on cancer cells to help the immune system attack them.

Pomalidomide: This is a medication used to treat multiple myeloma. It works by helping the immune system fight cancer and by stopping the growth of cancer cells.

Teclistamab: This is an investigational drug being studied for its potential to treat multiple myeloma. It is designed to help the immune system recognize and destroy cancer cells.

Elotuzumab: This medication is used in combination with other drugs to treat multiple myeloma. It works by targeting a specific protein on the surface of cancer cells, helping the immune system to attack them.

Bortezomib: This is a medication used to treat multiple myeloma. It works by interfering with the growth of cancer cells, eventually leading to their death.

Dexamethasone: This is a steroid medication used to reduce inflammation and suppress the immune system. In cancer treatment, it is often used to help reduce side effects and improve the effectiveness of other cancer therapies.

Relapsed or Refractory Myeloma – This is a type of cancer that affects plasma cells, which are a kind of white blood cell found in the bone marrow. In this condition, the myeloma has either returned after treatment (relapsed) or has not responded to treatment (refractory). The disease progresses as abnormal plasma cells multiply, leading to bone damage, kidney problems, and a weakened immune system. Patients may experience symptoms such as bone pain, fatigue, and frequent infections. Over time, the disease can cause significant damage to bones and other organs. The progression of the disease varies, and it can become more challenging to manage as it advances.